Sources of HIV infection among men having sex with men and implications for prevention

Science Translational Medicine

Volumn 8, Issue 320, 2016, Pages

  Ratmann, Oliver ^a   Van Sighem, Ard ^b   Bezemer, Daniela ^b   Gavryushkina, Alexandra ^c   Jurriaans, Suzanne ^d   Wensing, Annemarie ^e   De Wolf, Frank ^a   Reiss, Peter ^b,d   Fraser, Christophe ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b STICHTING HIV MONITORING   (Netherlands)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DUTCHMAN; EUROPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEN WHO HAVE SEX WITH MEN; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; VACCINATION; VIRUS TRANSMISSION; HIV INFECTIONS; MALE HOMOSEXUALITY; NETHERLANDS; PHYLOGENY; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ADULT; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; NETHERLANDS; PHYLOGENY;

EID: 84954555057     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad1863     Document Type: Article

References (53)

1. M. S. Cohen, Y. Q. Chen, M. McCauley, T. Gamble, M. C. Hosseinipour, N. Kumarasamy, J. G. Hakim, J. Kumwenda, B. Grinsztejn, J. H. S. Pilotto, S. V. Godbole, S. Mehendale, S. Chariyalertsak, B. R. Santos, K. H. Mayer, I. F. Hoffman, S. H. Eshleman, E. Piwowar-Manning, L.Wang, J.Makhema, L. A. Mills, G. de Bruyn, I. Sanne, J. Eron, J. Gallant, D. Havlir, S. Swindells, H. Ribaudo, V. Elharrar, D. Burns, T. E. Taha, K. Nielsen-Saines, D. Celentano, M. Essex, T. R. Fleming, Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493-505 (2011).
2. A. Rodger, T. Bruun, V. Cambiano, P. Vernazza, V. Estrada, J. Van Lunzen, S. Collins, A. M. Geretti, A. Phillips, J. Lundgren, HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER Study, 21st Conference on Retroviruses and Opportunistic Infections (CROI'14), Boston, MA, 3 to 6 March 2014.
3. C. Beyrer, S. D. Baral, F. van Griensven, S. M. Goodreau, S. Chariyalertsak, A. L. Wirtz, R. Brookmeyer, Global epidemiology of HIV infection in men who have sex with men. Lancet 380, 367-377 (2012).
4. P. S. Sullivan, A. Carballo-Diéguez, T. Coates, S. M. Goodreau, I. McGowan, E. J. Sanders, A. Smith, P. Goswami, J. Sanchez, Successes and challenges of HIV prevention in men who have sex with men. Lancet 380, 388-399 (2012).
5. World Health Organization, Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV (WHO, Geneva, 2015).
6. A. Fogarty, L. Mao, I. Zablotska Manos, H. R. Santana, G. Prestage, J. Rule, P. Canavan, D. Murphy, D. McGuigan, The Health in Men and Positive Health Cohorts: A Comparison of Trends in the Health and Sexual Behaviour of HIV-Negative and HIV-Positive Gay Men, 2002-2005 (National Centre in HIV Social Research, Sydney, 2006).
7. C. D. Pilcher, S. A. Fiscus, T. Q. Nguyen, E. Foust, L. Wolf, D. Williams, R. Ashby, J. O. O'Dowd, J. T. McPherson, B. Stalzer, L. Hightow, W. C. Miller, J. J. Eron Jr., M. S. Cohen, P. A. Leone, Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 352, 1873-1883 (2005).
8. H. A. Weiss, J. N. Wasserheit, R. V. Barnabas, R. J. Hayes, L. J. Abu-Raddad, Persisting with prevention: The importance of adherence for HIV prevention. Emerg. Themes Epidemiol. 5, 8 (2008).
9. A. van Sighem, L. Gras, A. Kesselring, C. Smit, I. Engelhard, I. Stolte, P. Reiss, Monitoring Report 2013: Of Human Immunodeficiency Virus Infection in the Netherlands (Stichting HIV Monitoring, Amsterdam, 2013).
10. T. T.-Y. Lam, C.-C. Hon, J. W. Tang, Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections. Crit. Rev. Clin. Lab. Sci. 47, 5-49 (2010).
11. D. P. Wilson, HIV treatment as prevention: Natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLOS Med. 9, e1001231 (2012).
12. E. Romero-Severson, H. Skar, I. Bulla, J. Albert, T. Leitner, Timing and order of transmission events is not directly reflected in a pathogen phylogeny. Mol. Biol. Evol. 31, 2472-2482 (2014).
13. D. Pillay, A. Rambaut, A. M. Geretti, A. J. L. Brown, HIV phylogenetics. BMJ 335, 460-461 (2007).
14. B. Vrancken, A. Rambaut, M. A. Suchard, A. Drummond, G. Baele, I. Derdelinckx, E. VanWijngaerden, A.-M. Vandamme, K. Van Laethem, P. Lemey, The genealogical population dynamics of HIV-1 in a large transmission chain: Bridging within and among host evolutionary rates. PLOS Comput. Biol. 10, e1003505 (2014).
15. P. Lemey, I. Derdelinckx, A. Rambaut, K. Van Laethem, S.Dumont, S. Vermeulen, E. VanWijngaerden, A.-M. Vandamme, Molecular footprint of drug-selective pressure in a human immunodeficiency virus transmission chain. J. Virol. 79, 11981-11989 (2005).
16. N. B. Carnegie, R. Wang, V. Novitsky, V. De Gruttola, Linkage of viral sequences among HIVinfected village residents in Botswana: Estimation of linkage rates in the presence of missing data. PLOS Comput. Biol. 10, e1003430 (2014).
17. F. van Griensven, T. H. Holtz,W. Thienkrua, W. Chonwattana, W.Wimonsate, S. Chaikummao, A. Varangrat, T. Chemnasiri, W. Sukwicha, M. E. Curlin, T. Samandari, A. Chitwarakorn, P. A. Mock, Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006-13: An observational study. Lancet HIV 2, e64-e70 (2015).
18. F. D. H. Koedijk, B. H. B. van Benthem, E. M. D. C. Vrolings, W. Zuilhof, M. A. B. van der Sande, Increasing sexually transmitted infection rates in young men having sex with men in the Netherlands, 2006-2012. Emerg. Themes Epidemiol. 11, 12 (2014).
19. R. M. Grant, J. R. Lama, P. L. Anderson, V. McMahan, A. Y. Liu, L. Vargas, P. Goicochea, M. Casapia, J. V. Guanira-Carranza, M. E. Ramirez-Cardich, O. Montoya-Herrera, T. Fernández, V. G. Veloso, S. P. Buchbinder, S. Chariyalertsak, M. Schechter, L.-G. Bekker, K. H. Mayer, E. G. Kallás, K. R. Amico, K. Mulligan, L. R. Bushman, R. J. Hance, C. Ganoza, P. Defechereux, B. Postle, F. Wang, J. J. McConnell, J.-H. Zheng, J. Lee, J. F. Rooney, H. S. Jaffe, A. I. Martinez, D. N. Burns, D. V. Glidden, iPrEx Study Team, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587-2599 (2010).
20. S. McCormack, D. T. Dunn, M. Desai, D. I. Dolling, M. Gafos, R. Gilson, A. K. Sullivan, A. Clarke, I. Reeves, G. Schembri, N. Mackie, C. Bowman, C. J. Lacey, V. Apea, M. Brady, J. Fox, S. Taylor, S. Antonucci, S. H. Khoo, J. Rooney, A. Nardone, M. Fisher, A. McOwan, A. N. Phillips, A. M. Johnson, B. Gazzard, O. N. Gill, Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic openlabel randomised trial. Lancet S0140-6736(15)00056-2 (2015).
21. J. M. Molina, C. Capitant, B. Spire, G. Pialoux, C. Chidiac, I. Charreau, C. Tremblay, L. Meyer, J. F. Delfraissy, On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial, Conference on Retroviruses and Opportunistic Infections (CROI'15), Seattle, WA, 23 to 26 February 2015.
22. F. Tanser, T. Bärnighausen, E. Grapsa, J. Zaidi, M.-L. Newell, High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339, 966-971 (2013).
23. D. Frentz, A. M. J. Wensing, J. Albert, D. Paraskevis, A. B. Abecasis, O. Hamouda, L. B. Jørgensen, C. Kücherer, D. Struck, J.-C. Schmit, B. Åsjö, C. Balotta, D. Beshkov, R. J. Camacho, B. Clotet, S. Coughlan, S. De Wit, A. Griskevicius, Z. Grossman, A. Horban, T. Kolupajeva, K. Korn, L. G. Kostrikis, K. Liitsola, M. Linka, C. Nielsen, D. Otelea, R. Paredes, M. Poljak, E. Puchhammer-Stöckl, A. Sönnerborg, D. Stanekova, M. Stanojevic, A.-M. Vandamme, C. A. B. Boucher, D. A. M. C. Van de Vijver, SPREAD Programme, Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology 10, 36 (2013).
24. B. G. Brenner, M. A. Wainberg, Future of phylogeny in HIV prevention. J. Acquir. Immune Defic. Syndr. 63, S248-S254 (2013).
25. A. B. Cope, K. A. Powers, J. D. Kuruc, P. A. Leone, J.A.Anderson, L.-H. Ping, L. P. Kincer, R. Swanstrom, V. L. Mobley, E. Foust, C. L. Gay, J. J. Eron, M. S. Cohen, W. C. Miller, Ongoing HIV transmission and the HIV care continuum in North Carolina. PLOS One 10, e0127950 (2015).
26. J. Skarbinski, E. Rosenberg, G. Paz-Bailey, H. I. Hall, C. E. Rose, A. H. Viall, J. L. Fagan, A. Lansky, J. H. Mermin, Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern. Med. 175, 588-596 (2015).
27. E. S. Rosenberg, G. A. Millett, P. S. Sullivan, C. del Rio, J. W. Curran, Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: A modeling study. Lancet HIV 1, e112-e118 (2014).
28. INSIGHT START Study Group, J. D. Lundgren, A. G. Babiker, F. Gordin, S. Emery, B. Grund, S. Sharma, A. Avihingsanon, D. A. Cooper, G. Fätkenheuer, J. M. Llibre, J. M. Molina, P. Munderi, M. Schechter, R. Wood, K. L. Klingman, S. Collins, H. C. Lane, A. N. Phillips, J. D. Neaton, Initiation of antiretroviral therapy in early asymptomatic HIV infection. N. Engl. J. Med. 373, 795-807 (2015).
29. E. M. Volz, E. Ionides, E. O. Romero-Severson, M.-G. Brandt, E. Mokotoff, J. S. Koopman, HIV-1 transmission during early infection in men who have sex with men: A phylodynamic analysis. PLOS Med. 10, e1001568 (2013).
30. Truvada Approved to Reduce the Risk of Sexually Transmitted HIV in People Who Are Not Infected with the Virus (U.S. Food and DrugAdministration, Silver Spring, MD, 2012).
31. R.M. Grant, P. L. Anderson, V. McMahan, A. Liu, K. R. Amico, M. Mehrotra, S. Hosek, C.Mosquera, M. Casapia, O. Montoya, S. Buchbinder, V. G. Veloso, K. Mayer, S. Chariyalertsak, L.-G. Bekker, E. G. Kallas, M. Schechter, J. Guanira, L. Bushman, D. N. Burns, J. F. Rooney, D. V. Glidden, iPrex study team, Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. Lancet Infect. Dis. 14, 820-829 (2014).
32. A. Liu, S. Cohen, S. Follansbee, D. Cohan, S. Weber, D. Sachdev, S. Buchbinder, Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLOS Med. 11, e1001613 (2014).
33. J. P. Bil, U. Davidovich, W. M. van der Veldt, M. Prins, H. J. C. de Vries, G. J. B. Sonder, I. G. Stolte, What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A crosssectional study. AIDS 29, 955-964 (2015).
34. M. J. Mimiaga, J. M. White, D. S. Krakower, K. B. Biello, K. H. Mayer, Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care 26, 684-693 (2014).
35. K. H. Mayer, S. Hosek, S. Cohen, A. Liu, J. Pickett, M. Warren, D. Krakower, R. Grant, Antiretroviral pre-exposure prophylaxis implementation in the United States: A work in progress. J. Int. AIDS Soc. 18, 19980 (2015).
36. D. Pao, M. Fisher, S. Hué, G. Dean, G. Murphy, P. A. Cane, C. A. Sabin, D. Pillay, Transmission of HIV-1 during primary infection: Relationship to sexual risk and sexually transmitted infections. AIDS 19, 85-90 (2005).
37. N. Pant Pai, J. Sharma, S. Shivkumar, S. Pillay, C. Vadnais, L. Joseph, K. Dheda, R. W. Peeling, Supervised and unsupervised self-testing for HIV in high-and low-risk populations: A systematic review. PLOS Med. 10, e1001414 (2013).
38. N. Lorente, M. Preau, C. Vernay-Vaisse, M. Mora, J. Blanche, J. Otis, A. Passeron, J.-M. Le Gall, P. Dhotte, M. P. Carrieri, M. Suzan-Monti, B. Spire, ANRS-DRAG Study Group, Expanding access to non-medicalized community-based rapid testing to men who have sex with men: An urgent HIV prevention intervention (The ANRS-DRAG study). PLOS One 8, e61225 (2013).
39. Time to Test for HIV: Expanding HIV Testing in Healthcare and Community Services in England (Health Protection Agency, London, 2011).
40. G. B. Gomez, A. Borquez, K. K. Case, A. Wheelock, A. Vassall, C. Hankins, The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: A systematic review of cost-effectiveness modelling studies. PLOS Med. 10, e1001401 (2013).
41. R. B. Birger, T. B. Hallett, A. Sinha, B. T. Grenfell, S. L. Hodder, Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey. Clin. Infect. Dis. 58, 274-284 (2014).
42. J. Heuker, G. J. B. Sonder, I. Stolte, R. Geskus, A. van den Hoek, High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: Indications for ongoing sexual risk behaviour. AIDS 26, 505-512 (2012).
43. V. A. Johnson, V. Calvez, H. F. Günthard, R. Paredes, D. Pillay, R. W. Shafer, A. M. Wensing, D. D. Richman, Update of the drug resistance mutations in HIV-1: March 2013. Top. Antivir. Med. 21, 6-14 (2013).
44. B. D. Rice, J. Elford, Z. Yin, V. C. Delpech, A new method to assign country of HIV infection among heterosexuals born abroad and diagnosed with HIV. AIDS 26, 1961-1966 (2012).
45. A. M. Kozlov, A. J. Aberer, A. Stamatakis, ExaML version 3: A tool for phylogenomic analyses on supercomputers. Bioinformatics 31, 2577-2579 (2015).
46. T. Leitner, D. Escanilla, C. Franzén, M. Uhlén, J. Albert, Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc. Natl. Acad. Sci. U.S.A. 93, 10864-10869 (1996).
47. A. van Sighem, F. Nakagawa, D. De Angelis, C. Quinten, D. Bezemer, E. O. de Coul, M. Egger, F. de Wolf, C. Fraser, A. Phillips, Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data. Epidemiology 26, 653-660 (2015).
48. Longitudinal Analysis of the Trajectories of CD4 Cell Counts (Health Protection Agency, London, 2011).
49. D. Bezemer, F. de Wolf, M. C. Boerlijst, A. van Sighem, T. D. Hollingsworth, C. Fraser, 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: An in depth mathematical model-based analysis. Epidemics 2, 66-79 (2010).
50. S. H. Eshleman, S. E. Hudelson, A. D. Redd, L.Wang, R. Debes, Y. Q. Chen, C. A. Martens, S. M. Ricklefs, E. J. Selig, S. F. Porcella, S. Munshaw, S. C. Ray, E. Piwowar-Manning, M. McCauley, M. C. Hosseinipour, J. Kumwenda, J. G. Hakim, S. Chariyalertsak, G. de Bruyn, B. Grinsztejn, N. Kumarasamy, J. Makhema, K. H. Mayer, J. Pilotto, B. R. Santos, T. C. Quinn, M. S. Cohen, J. P. Hughes, Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J. Infect. Dis. 204, 1918-1926 (2011).
51. A. Gavryushkina, D. Welch, T. Stadler, A. J. Drummond, Bayesian inference of sampled ancestor trees for epidemiology and fossil calibration. PLOS Comput. Biol. 10, e1003919 (2014).
52. S. B. McCombs, E. McCray, D. A. Wendell, P. A. Sweeney, I. M. Onorato, Epidemiology of HIV-1 infection in bisexual women. J. Acquir. Immune Defic. Syndr. 5, 850-852 (1992).
53. B. Efron, R. J. Tibshirani, An Introduction to the Bootstrap (Chapman and Hall, Boca Raton, FL, 1998).